{"transactions":[{"id":2037248,"issuer":{"id":8580,"kind":"organization","name":"AETHLON MEDICAL INC","symbol":"AEMD"},"owners":[{"id":117405,"kind":"person","name":"Arnold Lee D","position":1,"cik":"0001613258","reported_name":"Arnold Lee D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-02T21:14:07.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":60620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest and become exercisable on February 1, 2024, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":60620,"derivative":{"exercise_price":0.69,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":60620},"source":{"system":"sec-edgar","filing":"0001209191-23-006200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882291/000120919123006200/doc4.xml","form_type":"4"}},{"id":2415804,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":117405,"kind":"person","name":"Arnold Lee D","position":1,"cik":"0001613258","reported_name":"Arnold Lee D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-02T19:04:22.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in substantially equal monthly installments over four years from February 1, 2022, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":100000,"derivative":{"exercise_price":11.32,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-004214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1613258/000089924322004214/doc4.xml","form_type":"4"}}]}